Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure

NARecruitingINTERVENTIONAL
Enrollment

1,360

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2029

Conditions
Heart Failure
Interventions
DIAGNOSTIC_TEST

NT-proBNP

blood sample to measure N-terminal prohormone of B-type natriuretic peptide at local laboratory

DIAGNOSTIC_TEST

AI echocardiogram

Artificial intelligence driven transthoracic echocardiogram

DIAGNOSTIC_TEST

electrocardiogram

tracing of electrical cardiac activity of the heart

OTHER

Cardiovascular physical examination

basic physiological measurements to include height (cm), weight (kg) and hip circumference (cm) and blood pressure (mmHg)

Trial Locations (3)

V5Z 1M9

RECRUITING

Vancouver General Hospital, Vancouver

H1T 1C8

NOT_YET_RECRUITING

Montreal Heart Institute, Montreal

J1H 5N4

NOT_YET_RECRUITING

University of Sherbrooke, Sherbrooke

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Centre for Cardiovascular Innovation

UNKNOWN

collaborator

NHS Greater Glasgow & Clyde

UNKNOWN

collaborator

HeartLife Foundation

UNKNOWN

collaborator

Canadian Heart Function Alliance

UNKNOWN

collaborator

Montreal Heart Institute

OTHER

lead

Cardiology Research UBC

OTHER